Advertisement

Topics

Renovus Capital Partners Company Profile

12:05 EDT 14th August 2018 | BioPortfolio

Founded in 2010, Renovus Capital Partners is an education, training and human capital focused private equity firm. Renovus is based outside of Philadelphia and manages $495 million of committed capital through two SBIC funds. To date, the firm has acquired nineteen portfolio companies in areas such as educational technology, educational content, classroom instruction, corporate consulting and training, and human capital. The firm is an active investor in profitable and growing enterprises where the Renovus team, in partnership with management, seeks to create value through operational improvements, strategic growth initiatives and acquisitions. More information can be found at http://www.renovuscapital.com.


News Articles [1315 Associated News Articles listed on BioPortfolio]

Aleph Capital and Crestview Partners Agree to €260M Equity Funding Commitment in DARAG to ...

LONDON and NEW YORK, July 30, 2018 /PRNewswire/ -- Aleph Capital Partners LLP ("Aleph Capital") and Crestview Partners ("Crestview") have today announced that funds under Read more...

Medigene-Aktie: Rückzug von Leerverkäufer GSA Capital Partners hat an Dynamik gewonnen!

Martinsried (www.aktiencheck.de) - Leerverkäufer GSA Capital Partners LLP hat Netto-Leerverkaufsposition in Medigene-Aktien stark verringert: Die Leerverkäufer des Hedgefonds GSA Capital Partners L....

Honest Buildings Expands Series B Round to $21M with Additional Real Estate-Owner Investments

They join existing Series B industry investors Brookfield Property Partners, Rudin Ventures and C-III Capital Partners, in addition to leading venture capital funds Navitas Capital, Read more...

CStone closes $260mm Series B round; largest in Chinese biopharm history

Immuno-oncology firm CStone Pharmaceuticals Co. Ltd. raised $260mm through its Series B round, the largest funding of its kind in Chinese biopharma history. GIC Private Ltd. led and was joined by new ...

Oversubscribed Series B brings $110mm to Precision BioSciences

Precision BioSciences (gene editing) raised $110mm through an oversubscribed Series B round. ArrowMark Partners led and was joined by new investors Franklin Templeton Investments, Cowen Healthcare Inv...

Medigene-Aktie: Short-Attacke von GSA Capital Partners geht weiter

Martinsried (www.aktiencheck.de) - Leerverkäufer GSA Capital Partners LLP stockt Netto-Leerverkaufsposition in Medigene-Aktien nun deutlicher auf: Die Leerverkäufer des Hedgefonds GSA Capital Partn....

Medigene-Aktie: Leerverkäufer GSA Capital Partners hat den Rückwärtsgang eingelegt!

Martinsried - Leerverkäufer GSA Capital Partners LLP baut Netto-Leerverkaufsposition in Medigene-Aktien etwas ab: Die Leerverkäufer des Hedgefonds GSA Capital Partners LLP haben den Rückwärtsgang ...

TCR2 closes $125mm Series B round

TCR2 Therapeutics Inc. (immuno-oncology) raised $125mm through its Series B round. Curative Ventures and 6 Dimensions Capital co-led and were joined by additional new investors Redmile Group, ArrowMar...

PubMed Articles [352 Associated PubMed Articles listed on BioPortfolio]

Health and social care coordination for severe and persistent mental illness in Australia: a mixed methods evaluation of experiences with the Partners in Recovery Program.

Care coordination has been identified as a person-centred response to the difficulty in meeting the needs of people with severe and persistent mental illness and complex needs. This study evaluated th...

What is the association between social capital and diabetes mellitus? A systematic review.

Social capital has been included as an element that could influence the self-perception of health, mortality and mental diseases. We systematically reviewed papers that studied the influence of social...

Social Capital and Health Among Older Chinese Immigrants: a Cross-Sectional Analysis of a Sample in a Canadian Prairie City.

The objective of this study was to examine the relationship between social capital and health among Chinese immigrants. The sample included 101 older Chinese immigrants aged 60 to 96 who were recruite...

"Who'll do all these if I'm not around?": Bonding social capital and health and well-being of inpatients.

Although social capital influences health-related decisions and behavioural patterns in many developing countries, minimal attention has been paid to the nuances of its effect on healthcare. This pape...

Association Between Community Social Capital and Hospital Readmission Rates.

Hospital readmissions remain frequent, and are partly attributable to patients' social needs. The authors sought to examine whether local community levels of social capital are associated with hospita...

Clinical Trials [347 Associated Clinical Trials listed on BioPortfolio]

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Teachers and Parents as Partners During Middle School RCT

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Companies [1877 Associated Companies listed on BioPortfolio]

Renovus Capital Partners

Founded in 2010, Renovus Capital Partners is an education, training and human capital focused private equity firm. Renovus is based outside of Philadelphia and manages $495 millio...

Oak Hill Capital Partners

Oak Hill Capital Partners is a private equity firm with more than $8.2 billion of committed capital from leading entrepreneurs, endowments, foundations, corporations, pension fund...

Thompson Street Capital Partners

Thompson Street Capital Partners has $450 million in capital under management. The private equity firm makes investments in manufacturing, service and distribution businesses. The fund's philosophy is...

Amulet Capital Partners, LP

Amulet Capital Partners, LP is a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector. Amulet seeks to achieve long...

Harbinger Capital Partners

Harbinger Capital Partners is a multi-billion dollar private investment fund based in New York which employs a fundamental, intensive research-based approach to investing. ...

More Information about "Renovus Capital Partners" on BioPortfolio

We have published hundreds of Renovus Capital Partners news stories on BioPortfolio along with dozens of Renovus Capital Partners Clinical Trials and PubMed Articles about Renovus Capital Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Renovus Capital Partners Companies in our database. You can also find out about relevant Renovus Capital Partners Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.


Corporate Database Quicklinks



Searches Linking to this Company Record